Mela Sciences Inc ( NASDAQ: MELA ), company is waiting for review of its Melanoma detection device called Melafind from FDA. Company's CEO Mr. Gulfo was talking in an exclusive interview and hoping that company will receive a review soon. Keep an eye on the stock as it might shoot up after the FDA review. Company has submitted amended PMA ( Pre marketing approval ) to FDA hoping to get a positive response from it.



Below is the exclusive interview.